Jump to content

Homosildenafil

From Wikipedia, the free encyclopedia
Homosildenafil
Clinical data
ATC code
  • None
Identifiers
  • 5-[2-Ethoxy-5-(4-ethylpiperazin-1-yl)sulfonylphenyl]-1-methyl-3-propyl-4H-pyrazolo[4,3-d]pyrimidin-7-one
CAS Number
PubChemCID
ChemSpider
UNII
CompTox Dashboard(EPA)
Chemical and physical data
FormulaC23H32N6O4S
Molar mass488.61g·mol−1
3D model (JSmol)
  • CCCC1=NN(C)C2=C1N=C(NC2=O)C1=CC(=CC=C1OCC)S(=O)(=O)N1CCN(CC)CC1
  • InChI=1S/C23H32N6O4S/c1-5-8-18-20-21(27(4)26-18)23(30)25-22(24-20)17-15-16(9-10-19(17)33-7-3)34(31,32)29-13-11-28(6-2)12-14-29/h9-10,15H,5-8,11-14H2,1-4H3,(H,24,25,30)
  • Key:MJEXYQIZUOHDGY-UHFFFAOYSA-N

Homosildenafil(also known asmethyl-sildenafil) is a syntheticdrugwhich acts as aphosphodiesterase inhibitor.[1]It is ananalogofsildenafilandvardenafil.Homosildenafil was first identified as an adulterant in sex enhancement products in 2003 and was more recently detected in dietary supplements.[2][3][4][5]

Homosildenafil has 35% the PDE5 inhibition activity of sildenafil itself with similar selectivity.[1]

Sildenafil is mainly metabolized by the microsomalisozymesCYP3A4with secondary metabolism byCYP2C9.The major active metabolite isN-desmethylsildenafil. The plasma level of the equivalent homosildenafil metabolite reaches 40% of sildenafil's bioavailability. TheN-desmethyl metabolite is further metabolized, with a half-life of 4 hours.[6][7][8][9]

See also

[edit]

References

[edit]
  1. ^abCorbin JD, Beasley A, Blount MA, Francis SH (November 2004). "Vardenafil: structural basis for higher potency over sildenafil in inhibiting cGMP-specific phosphodiesterase-5 (PDE5)".Neurochemistry International.45(6): 859–63.doi:10.1016/j.neuint.2004.03.016.PMID15312980.S2CID25178860.
  2. ^Shin MH, Hong MK, Kim WS, Lee YJ, Jeoung YC (September 2003). "Identification of a new analogue of sildenafil added illegally to a functional food marketed for penile erectile dysfunction".Food Additives and Contaminants.20(9): 793–6.doi:10.1080/0265203031000121455.PMID13129773.S2CID30941705.
  3. ^Gryniewicz CM, Reepmeyer JC, Kauffman JF, Buhse LF (April 2009). "Detection of undeclared erectile dysfunction drugs and analogues in dietary supplements by ion mobility spectrometry".Journal of Pharmaceutical and Biomedical Analysis.49(3): 601–6.doi:10.1016/j.jpba.2008.12.002.PMID19150190.
  4. ^"Advisory -" Forta for Men "sex enhancement product recalled; contains undeclared drug".PR Newswire. 2014.Retrieved28 April2015.
  5. ^Zou P, Oh SS, Hou P, Low MY, Koh HL (February 2006). "Simultaneous determination of synthetic phosphodiesterase-5 inhibitors found in a dietary supplement and pre-mixed bulk powders for dietary supplements using high-performance liquid chromatography with diode array detection and liquid chromatography-electrospray ionization tandem mass spectrometry".Journal of Chromatography A.1104(1–2): 113–22.doi:10.1016/j.chroma.2005.11.103.PMID16364350.
  6. ^WO 2001080860,De Tejada IS, Ferguson KM, Whitaker JS, "Daily treatment for erectile dysfunction using a pde5 inhibitor", published 1 November 2001, assigned to Lilly ICOS LLC.
  7. ^US 20090074796,Borrello IM, Serafini P, Noonan KA, Bronte V, "Pde5 inhibitor compositions and methods for immunotherapy", published 19 March 2009, assigned to ohns Hopkins University.
  8. ^US 8497370,Chen IJ, "Processes for preparing amine salts of sildenafil-analogues and use thereof", issued 30 July 2013, assigned to Kaohsiung Medical University.
  9. ^CN 101555512,Yang X, Guo J, Huang Z, "Preparation method for monoclonal antibody specifically binding vardenafil and analog thereof", issued 30 July 2013, assigned to Kaohsiung Medical University.